Related Experiment Videos
Computed tomographic appearance of methotrexate-induced necrotizing leukoencephalopathy
Radiology
|February 1, 1977
Abstract:
A case of methotrexate-induced brain damage is presented. Computed tomography (CT) demonstrated a high-density mass lesion with a low-density area in the white matter which pathologically represented a large area of acute necrotizing cerebritis. CT appearance was indistinguishable from brain abscess.
Insights
Methotrexate can cause brain damage, presenting as lesions on CT scans. These lesions mimic brain abscesses but are actually necrotizing cerebritis.
Area of Science:
- Neurology
- Radiology
- Toxicology
Background:
- Methotrexate is a chemotherapy agent with known neurotoxicity.
- Brain damage from methotrexate can be challenging to diagnose.
- Early identification of methotrexate neurotoxicity is crucial.
Observation:
- A case study detailing methotrexate-induced brain damage.
- Computed tomography (CT) revealed a high-density mass lesion with central low density in the white matter.
- Pathological examination confirmed acute necrotizing cerebritis.
Findings:
- The CT appearance of methotrexate-induced brain damage was indistinguishable from a brain abscess.
- Necrotizing cerebritis represents a severe form of white matter damage.
- This case highlights the imaging similarities between toxic encephalopathy and infection.
Implications:
- Radiologists and clinicians should consider methotrexate neurotoxicity in patients presenting with brain lesions.
- Differential diagnosis of brain abscess should include methotrexate-induced brain damage.
- Further research into the specific imaging biomarkers for methotrexate neurotoxicity is warranted.